Shandong Buchang Pharmaceuticals Co Ltd Strategic Asset Allocation Index
Shandong Buchang Pharmaceuticals Co Ltd strategic asset allocation index. Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Strategic Asset Allocation Index of 52.0% as of June 2023. Strategic assets (PP&E of CN¥6.21 Billion plus long-term investments of CN¥-) total CN¥6.21 Billion, measured against net assets of CN¥11.93 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Shandong Buchang Pharmaceuticals Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shandong Buchang Pharmaceuticals Co Ltd (2011–2022)
Strategic asset allocation index of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2022. This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 52.0%, representing strategic assets of CN¥6.21 Billion against net assets of CN¥11.93 Billion CNY. Check 603858 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Shandong Buchang Pharmaceuticals Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Shandong Buchang Pharmaceuticals Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shandong Buchang Pharmaceuticals Co Ltd (603858) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 51.3% | CN¥6.30 Billion | CN¥6.30 Billion | CN¥- | CN¥12.28 Billion | ▲ +10.4 pp |
| 2021 | 41.0% | CN¥5.92 Billion | CN¥5.92 Billion | CN¥- | CN¥14.45 Billion | ▲ +2.3 pp |
| 2020 | 38.7% | CN¥5.34 Billion | CN¥5.34 Billion | CN¥- | CN¥13.81 Billion | ▲ +4.4 pp |
| 2019 | 34.3% | CN¥4.73 Billion | CN¥4.73 Billion | CN¥- | CN¥13.79 Billion | ▲ +11.1 pp |
| 2018 | 23.1% | CN¥3.21 Billion | CN¥3.21 Billion | CN¥- | CN¥13.86 Billion | ▲ +4.0 pp |
| 2017 | 19.1% | CN¥2.53 Billion | CN¥2.53 Billion | CN¥- | CN¥13.22 Billion | ▲ +4.9 pp |
| 2016 | 14.2% | CN¥1.81 Billion | CN¥1.81 Billion | CN¥- | CN¥12.71 Billion | ▼ -7.1 pp |
| 2015 | 21.4% | CN¥1.55 Billion | CN¥1.55 Billion | CN¥- | CN¥7.26 Billion | ▼ -5.5 pp |
| 2014 | 26.8% | CN¥1.19 Billion | CN¥1.19 Billion | CN¥- | CN¥4.45 Billion | ▲ +4.6 pp |
| 2013 | 22.3% | CN¥954.52 Million | CN¥954.52 Million | CN¥- | CN¥4.28 Billion | ▲ +4.2 pp |
| 2012 | 18.1% | CN¥728.45 Million | CN¥728.45 Million | CN¥- | CN¥4.02 Billion | ▲ +0.6 pp |
| 2011 | 17.5% | CN¥491.25 Million | CN¥491.25 Million | CN¥- | CN¥2.80 Billion | — |